404 related articles for article (PubMed ID: 36010271)
41. Prevalence of endocrine complications in transfusion dependent thalassemia in Hospital Pulau Pinang: A pilot study.
Lee KT; Lim SL; Goh AS
Med J Malaysia; 2020 Jan; 75(1):33-37. PubMed ID: 32008017
[TBL] [Abstract][Full Text] [Related]
42. Endocrine and bone disease in appropriately treated adult patients with beta-thalassemia major.
Baldini M; Forti S; Marcon A; Ulivieri FM; Orsatti A; Tampieri B; Airaghi L; Zanaboni L; Cappellini MD
Ann Hematol; 2010 Dec; 89(12):1207-13. PubMed ID: 20582415
[TBL] [Abstract][Full Text] [Related]
43. Detection of endocrine disorders in young children with multi-transfused thalassemia major.
Mahmoud RA; Khodeary A; Farhan MS
Ital J Pediatr; 2021 Jul; 47(1):165. PubMed ID: 34332621
[TBL] [Abstract][Full Text] [Related]
44. Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia.
Angelopoulos NG; Goula A; Rombopoulos G; Kaltzidou V; Katounda E; Kaltsas D; Tolis G
J Bone Miner Metab; 2006; 24(2):138-45. PubMed ID: 16502121
[TBL] [Abstract][Full Text] [Related]
45. Thalassemia.
Cohen AR; Galanello R; Pennell DJ; Cunningham MJ; Vichinsky E
Hematology Am Soc Hematol Educ Program; 2004; ():14-34. PubMed ID: 15561674
[TBL] [Abstract][Full Text] [Related]
46. Serum or plasma ferritin concentration as an index of iron deficiency and overload.
Garcia-Casal MN; Pasricha SR; Martinez RX; Lopez-Perez L; Peña-Rosas JP
Cochrane Database Syst Rev; 2021 May; 5(5):CD011817. PubMed ID: 34028001
[TBL] [Abstract][Full Text] [Related]
47. Endocrine Complications of Surgical Treatment of Thyroid Cancer: An Update.
Iglesias P; Díez JJ
Exp Clin Endocrinol Diabetes; 2017 Sep; 125(8):497-505. PubMed ID: 28444664
[TBL] [Abstract][Full Text] [Related]
48. Pulmonary functions in Egyptian children with transfusion-dependent β-thalassemia.
Abd El Hakeem AA; Mousa SMO; AbdelFattah MT; AbdelAziz AO; Abd El Azeim SS
Transfus Med; 2019 Feb; 29(1):55-60. PubMed ID: 30779248
[TBL] [Abstract][Full Text] [Related]
49. Fertility in female patients with thalassemia.
Skordis N; Christou S; Koliou M; Pavlides N; Angastiniotis M
J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():935-43. PubMed ID: 10091168
[TBL] [Abstract][Full Text] [Related]
50. The impact of genotype on endocrine complications in thalassaemia major.
Skordis N; Michaelidou M; Savva SC; Ioannou Y; Rousounides A; Kleanthous M; Skordos G; Christou S
Eur J Haematol; 2006 Aug; 77(2):150-6. PubMed ID: 16800840
[TBL] [Abstract][Full Text] [Related]
51. Endocrine profile of β-thalassemia major patients followed from childhood to advanced adulthood in a tertiary care center.
De Sanctis V; Elsedfy H; Soliman AT; Elhakim IZ; Soliman NA; Elalaily R; Kattamis C
Indian J Endocrinol Metab; 2016; 20(4):451-9. PubMed ID: 27366710
[TBL] [Abstract][Full Text] [Related]
52. Growth and endocrine function in thalassemia major in childhood and adolescence.
Delvecchio M; Cavallo L
J Endocrinol Invest; 2010 Jan; 33(1):61-8. PubMed ID: 20203539
[TBL] [Abstract][Full Text] [Related]
53. Gender differences in the prevalence and severity of bone disease in thalassaemia.
Kyriakou A; Savva SC; Savvides I; Pangalou E; Ioannou YS; Christou S; Skordis N
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():116-22. PubMed ID: 19337164
[TBL] [Abstract][Full Text] [Related]
54. Spine bone texture assessed by trabecular bone score (TBS) to evaluate bone health in thalassemia major.
Baldini M; Ulivieri FM; Forti S; Serafino S; Seghezzi S; Marcon A; Giarda F; Messina C; Cassinerio E; Aubry-Rozier B; Hans D; Cappellini MD
Calcif Tissue Int; 2014 Dec; 95(6):540-6. PubMed ID: 25348077
[TBL] [Abstract][Full Text] [Related]
55. Longitudinal study of ICET-A on glucose tolerance, insulin sensitivity and β-cell secretion in eleven β-thalassemia major patients with mild iron overload.
De Sanctis V; Soliman AT; Daar S; Tzoulis P; Di Maio S; Kattamis C
Acta Biomed; 2023 Feb; 94(1):e2023011. PubMed ID: 36786253
[TBL] [Abstract][Full Text] [Related]
56. Pathogenesis and management of osteoporosis in thalassemia.
Voskaridou E; Terpos E
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():86-93. PubMed ID: 19337161
[TBL] [Abstract][Full Text] [Related]
57. Fertility and pregnancy in Iranian thalassemia patients: An update on transfusion complications.
Takhviji V; Zibara K; Azarkeivan A; Mehrvar N; Mehrvar N; Mezginejad F; Khosravi A
Transfus Med; 2020 Oct; 30(5):352-360. PubMed ID: 32820581
[TBL] [Abstract][Full Text] [Related]
58. Study of Male Sex Hormone Levels in Male Egyptian Children with Beta-Thalassemia: Correlation with Iron load.
Hagag AA; Badraia IM; Elfarargy MS; El-Enein AMA
Endocr Metab Immune Disord Drug Targets; 2016; 16(2):124-130. PubMed ID: 27215646
[TBL] [Abstract][Full Text] [Related]
59. Spectrum Of HBB Gene Variants And Major Endocrine Complications In Thalassemia Patients Of Pakistan.
Ghafoor MB; Ujjan ID; Waryah AM; Memon FA
J Pak Med Assoc; 2023 Oct; 73(10):2013-2016. PubMed ID: 37876062
[TBL] [Abstract][Full Text] [Related]
60. Effect of different iron chelation regimens on bone mass in transfusion-dependent thalassemia patients.
Bordbar M; Haghpanah S; Zekavat OR; Saki F; Bazrafshan A; Bozorgi H
Expert Rev Hematol; 2019 Nov; 12(11):997-1003. PubMed ID: 31486684
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
